# Humana (HUM) — Earnings

HUM · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/hum/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $7.61 |
| EPS estimate | $7.26 |
| EPS surprise | +4.75% |
| Revenue surprise | +0.74% |
| Revenue | $40.9B |
| Revenue estimate | $40.6B |
| Reported | Jul 29, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/49071/000004907126000050/hum-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/654627be-4e6c-830e-36d3-31890ddb27c3.html) |

Humana reported Q2 2026 results on July 29, 2026. Earnings per share came in at $7.61, ahead of the $7.26 estimate by 4.75%. Revenue was $40.9 billion, above the $40.6 billion consensus by 0.74%. Compared with Q2 2025, EPS rose about 21% from $6.27 and revenue rose about 26% from $32.4 billion.

The longer record shows rising sales and uneven earnings. Annual revenue rose from $92.9 billion in 2022 to $129.6 billion in 2025, about 40% higher. Annual EPS was $25.21 in 2022 and $25.99 in 2023, then $16.19 in 2024 and $17.13 in 2025. Humana posted losses in Q4 2023, Q4 2024 and Q4 2025, the last at $3.96 per share. The high in the table was $11.58 per share in Q1 2025. The first half of 2026 adds up to $17.92, about the same as the $17.85 of the first half of 2025. Over the last 20 quarters, Humana beat the EPS estimate 19 times. The only miss was Q4 2023, a loss against an expected profit.

Humana reported Q3 between October 30 and November 5 in each of the past five years. That points to late October or early November 2026 for the next report.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 29, 2026 | $7.26 | $7.61 | 4.75% | $40.6B | $40.9B |
| Q1 2026 | Apr 29, 2026 | $10.20 | $10.31 | 1.11% | $39.4B | $39.6B |
| Q4 2025 | Feb 11, 2026 | −$4.00 | −$3.96 | 1.05% | $32.0B | $32.5B |
| Q3 2025 | Nov 5, 2025 | $2.93 | $3.24 | 10.73% | $32.0B | $32.6B |
| Q2 2025 | Jul 30, 2025 | $5.92 | $6.27 | 5.96% | $31.9B | $32.4B |
| Q1 2025 | Apr 30, 2025 | $10.07 | $11.58 | 14.97% | $32.2B | $32.1B |
| Q4 2024 | Feb 11, 2025 | −$2.23 | −$2.16 | 3.19% | $28.8B | $29.2B |
| Q3 2024 | Oct 30, 2024 | $3.42 | $4.16 | 21.68% | $28.7B | $29.4B |
| Q2 2024 | Jul 31, 2024 | $5.86 | $6.96 | 18.69% | $28.5B | $29.5B |
| Q1 2024 | Apr 24, 2024 | $6.12 | $7.23 | 18.16% | $28.5B | $29.6B |
| Q4 2023 | Jan 25, 2024 | $0.81 | −$0.11 | -113.63% | $25.5B | $26.5B |
| Q3 2023 | Nov 1, 2023 | $7.16 | $7.78 | 8.62% | $25.6B | $26.4B |
| Q2 2023 | Aug 2, 2023 | $8.76 | $8.94 | 2.08% | $25.8B | $26.7B |
| Q1 2023 | Apr 26, 2023 | $9.27 | $9.38 | 1.18% | $26.4B | $26.7B |
| Q4 2022 | Feb 1, 2023 | $1.46 | $1.62 | 10.88% | $22.5B | $22.4B |
| Q3 2022 | Nov 2, 2022 | $6.28 | $6.88 | 9.62% | $22.8B | $22.8B |
| Q2 2022 | Jul 27, 2022 | $7.67 | $8.67 | 13.09% | $23.4B | $23.7B |
| Q1 2022 | Apr 27, 2022 | $6.80 | $8.04 | 18.23% | $23.5B | $24.0B |
| Q4 2021 | Feb 2, 2022 | $1.16 | $1.24 | 7.16% | $21.2B | $21.1B |
| Q3 2021 | Nov 3, 2021 | $4.68 | $4.83 | 3.31% | $20.9B | $20.9B |

## Frequently Asked Questions

### When did Humana (HUM) last report earnings?

Humana last reported on Jul 29, 2026, covering fiscal Q2 2026.

### Did HUM beat earnings estimates?

Yes. Humana reported EPS of $7.61 for Q2 2026 against a $7.26 estimate — a 4.75% beat.

### How much revenue did HUM report last quarter?

Humana reported $40.9B in revenue for Q2 2026, against a consensus estimate of $40.6B.

## Similar Stocks

- [CNC](https://www.lighthorse.io/tickers/cnc) — Centene Corporation Common Stock
- [CI](https://www.lighthorse.io/tickers/ci) — The Cigna Group Common Stock
- [MOH](https://www.lighthorse.io/tickers/moh) — Molina Healthcare Inc Common Stock
- [ELV](https://www.lighthorse.io/tickers/elv) — Elevance Health, Inc. Common Stock
- [UNH](https://www.lighthorse.io/tickers/unh) — UnitedHealth Group Incorporated Common Stock (DE)

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).